Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

21 juil. 2011 08h00 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals, Inc. Reaches Agreement With the FDA on a Special Protocol Assessment for the Phase 3 Clinical Study of AST-726

NEW YORK, July 21, 2011 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAND) announced that the Company has reached an agreement with the U.S. Food and Drug Administration (FDA) on a...
13 juil. 2011 16h00 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals, Inc. Announces Reverse Stock Split

NEW YORK, July 13, 2011 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) previously announced on Form 8-K that the Company's Certificate of Amendment to its Certificate of...
31 janv. 2011 12h11 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Achieves Ariston Merger Milestone

NEW YORK, Jan. 31, 2011 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced today that the company's Board of Directors has decided to continue development of AST-915, an orally...
10 janv. 2011 07h35 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Announces Entry Into Settlement and Release Agreement With Nordic Biotech

NEW YORK, Jan. 10, 2011 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced that on January 4, 2011, the company entered into a settlement and release agreement with Nordic...
16 déc. 2010 07h49 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Announces Preliminary Phase 1/2 Results for AST-915 in Essential Tremor

NEW YORK, Dec. 16, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced preliminary results today from a Phase 1/2 study of AST-915 for the treatment of essential tremor....
08 nov. 2010 07h39 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Awarded $245K Grant Under the U.S. Qualified Therapeutic Discovery Project Credit Program

NEW YORK, Nov. 8, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic...
11 oct. 2010 08h35 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals to Present at Precision IR Biotech, Healthcare & Pharmaceutical Virtual Conference

NEW YORK, Oct. 11, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) is scheduled to present at the Precision IR Biotech, Healthcare & Pharmaceutical Virtual Conference at...
14 avr. 2010 07h30 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Announces Private Placement Final Close at $3.0 Million

NEW YORK, April 14, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today announced the final close of its private placement in which it sold approximately 121 units, including...
12 mars 2010 07h35 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Completes Merger Transaction With Ariston Pharmaceuticals

NEW YORK, March 12, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today announced it has entered into a definitive agreement and plan of merger and completed the merger...
04 mars 2010 07h35 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Completes $2.5 Million Financing

NEW YORK, March 4, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today announced the private placement of $2,547,500 of its common stock and warrants to accredited...

Page précédente